Business Context and Reporting Period
Company: Universal Health Services, Inc.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2000
Operations: The Company operates acute care services and behavioral health care services across multiple facilities, including hospitals, ambulatory treatment centers, and specialized women's health centers.
Key Financial Metrics
| Metric | Q1 2000 | Q1 1999 |
|---|---|---|
| Net Revenues | $541.0 million | $520.1 million |
| Net Income | $28.6 million | $30.0 million |
| Earnings Per Share (Diluted) | $0.92 | $0.92 |
| EBITDAR | $94.3 million | $97.4 million |
| Operating Margin (EBITDAR/Revenue) | 17.4% | 18.7% |
| Net Cash from Operating Activities | $48.3 million | $73.1 million |
| Capital Expenditures | $30.7 million | $12.6 million |
| Cash and Cash Equivalents (End of Period) | $8.0 million | $10.5 million |
| Debt to Total Capitalization | 39% | 40% (Dec 31, 1999) |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 4% ($21 million) driven by acquisitions in Q2 1999 (behavioral health in IL, IN, NJ and acute care in TX) and organic growth at existing facilities.
- Profitability Decline: Net income decreased 4.6% and EBITDAR decreased 3.2%. Overall operating margins contracted from 18.7% to 17.4%.
- Segment Performance:
- Acute Care: Operating margins declined from 22.2% to 19.8% due to Medicare reimbursement reductions (BBA-97), Medicaid disproportionate share cuts ($11 million annual reduction), and higher indigent care costs.
- Behavioral Health: Operating margins improved from 17.6% to 18.3%, aided by higher margins at recently acquired facilities.
- Cash Flow: Operating cash flow decreased $25 million, primarily due to unfavorable timing of working capital accounts (compensation and payables) and increased capital expenditures ($31 million vs. $13 million prior year).
- Share Repurchases: The Company repurchased 170,000 shares for $6.7 million in Q1 2000.
Outlook, Risks, and Contingencies
- Acquisition Activity: Subsequent to the quarter, the Company agreed to acquire a 277-bed acute care facility in Enid, Oklahoma, expected to close in Q3 2000.
- Reimbursement Risks: Continued pressure from the Balanced Budget Act of 1997 (BBA-97) and Medicaid program redesigns in Texas and South Carolina. The Company anticipates a shift toward managed care, which typically offers lower reimbursement rates.
- Regulatory Compliance: Implementation of HIPAA regulations is expected to incur costs and operational changes, though specific implementation costs are not yet quantified.
- Liquidity: The Company maintains $226 million in unused borrowing capacity under a $400 million revolving credit facility. Commercial paper capacity was fully utilized as of March 31, 2000.
- Accounting Changes: The Company must adopt SFAS No. 133 (Derivatives and Hedging) effective January 1, 2001, which may increase earnings volatility.
Investor Verification Checklist
- Verify the impact of the $11 million annual reduction in Medicaid disproportionate share reimbursements on future margins.
- Monitor the integration and performance of the newly acquired Enid, Oklahoma facility.
- Assess the timing and cost implications of HIPAA compliance implementation.
- Review the Company's ability to maintain liquidity given the full utilization of the commercial paper program and high capital expenditure levels.
- Track the trend of the provision for doubtful accounts, which increased to $45.0 million in Q1 2000.